There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rani Therapeutics Holdings (RANI – Research Report), Apollo Medical Holdings (AMEH – Research Report) and Arcus Biosciences (RCUS – Research Report) with bullish sentiments.
Rani Therapeutics Holdings (RANI)
In a report released today, Andreas Argyrides from Wedbush maintained a Buy rating on Rani Therapeutics Holdings, with a price target of $8.00. The company’s shares closed last Monday at $3.59.
According to TipRanks.com, Argyrides is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Rani Therapeutics Holdings with a $12.40 average price target.
See today’s best-performing stocks on TipRanks >>
Apollo Medical Holdings (AMEH)
In a report released yesterday, David Larsen from BTIG maintained a Buy rating on Apollo Medical Holdings, with a price target of $45.00. The company’s shares closed last Monday at $35.87.
According to TipRanks.com, Larsen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Apollo Medical Holdings is a Moderate Buy with an average price target of $47.00, which is a 33.3% upside from current levels. In a report issued on January 24, Stifel Nicolaus also initiated coverage with a Buy rating on the stock with a $45.00 price target.
Arcus Biosciences (RCUS)
In a report released today, Kaveri Pohlman from BTIG maintained a Buy rating on Arcus Biosciences, with a price target of $70.00. The company’s shares closed last Monday at $15.30.
According to TipRanks.com, Pohlman is a 3-star analyst with an average return of
Arcus Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $43.25, representing a 186.4% upside. In a report issued on January 22, Mizuho Securities also maintained a Buy rating on the stock with a $51.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RANI:
